Home / Conditions / Obesity

Obesity

Obesity and Diabetes: Diabetes patients are considered obese when they have a Body Mass Index over 30. Such patients are at greater risk for a host of other problems cardiovascular disease, cancer, sleep apnea, and poor quality of life. Tremendous research is being done to control, manage, and reverse obesity in diabetics and the educated healthcare professional can help.

Can Weight Loss Delay Type 1 Diabetes? What the Pre-Symptomatic Data Really Show

Healthy food, exercise shoes, glucose meter, scale, and pancreas illustration representing weight and type 1 diabetes prevention research.

Efforts to prevent or delay type 1 diabetes have traditionally focused on the autoimmune attack that destroys insulin-producing beta cells. However, emerging research suggests metabolic stress may also influence how quickly vulnerable people progress to clinical disease. A 2026 TrialNet analysis found that autoantibody-positive people with overweight or obesity who …

Read More »

Amylin Is Making a Comeback: Why This Forgotten Hormone Is Back in the Spotlight

Medical illustration showing amylin hormone activity alongside insulin therapy, highlighting next-generation amylin-based treatments for diabetes and obesity.

For years, glucagon-like peptide-1 (GLP-1) receptor agonists have dominated conversations about diabetes and obesity treatment. However, another hormone is quietly returning to the spotlight. Amylin diabetes therapy is making a comeback as researchers develop a new generation of drugs designed to improve blood glucose control and support weight management. Amylin …

Read More »

The Glucagon Paradox: Why Activating a “Blood Sugar Hormone” Can Improve Metabolic Health

Medical illustration showing GLP-1, GIP, and glucagon receptors working together to improve metabolism, weight loss, liver health, and blood glucose control in triple agonist diabetes therapy.

For decades, glucagon has been viewed as insulin’s opposite. While insulin lowers blood glucose, glucagon raises it by signaling the liver to release stored sugar into the bloodstream. Because of this, glucagon has traditionally been considered a hormone to suppress in people living with type 2 diabetes. However, modern research …

Read More »

When Weight Loss Isn’t the Whole Story: Managing Binge Eating Disorder in Type 2 Diabetes

Healthcare professional counseling an adult with type 2 diabetes about binge eating disorder, with healthy foods, a glucose meter, and balanced meal planning on a table.

For many people living with binge eating disorder and type 2 diabetes, managing blood sugar isn’t just about counting carbohydrates or losing weight. Emotional eating, loss of control around food, and feelings of guilt can quietly interfere with diabetes care, even when someone is taking the right medications. Because of …

Read More »

Your Patient Is Taking a Compounded GLP-1. Now What?

Physician discussing compounded GLP-1 medication safety with a patient during a clinical consultation, with injectable medication vials and a syringe on the desk.

As demand for GLP-1 receptor agonists continues to outpace supply, many patients have turned to compounded medications obtained through telehealth companies, medical spas, wellness clinics, and compounding pharmacies. While these products may improve access for some individuals, they also introduce important clinical, regulatory, and medicolegal challenges. Providers increasingly encounter patients …

Read More »